格隆汇9月7日丨华康洁净(301235.SZ)发布公告，公司于近日收到持股5%以上股东阳光人寿出具的《关 于股份减持计划的告知函》，阳光人寿拟自本公告披露之日起15个交易日后的3个月内通过集中竞价、 大宗交易的方式减持不超过323.30万股，拟减持比例不超过公司总股本的3.0%(占剔除公司回购专用账 户股份后总股本的3.0978%)。 ...

Group 1 - The core point of the news is that Yangguang Life Insurance Co., Ltd. plans to reduce its stake in Huakang Clean (SZ 301235) by up to approximately 3% of the total share capital within three months, starting from 15 trading days after the announcement [1] - Huakang Clean's major revenue sources for the year 2024 are projected to be 90.01% from medical specialty technology services, 9.27% from the medical device industry, and 0.72% from other business income [1] - As of the report, Huakang Clean has a market capitalization of 3.5 billion yuan [2]

转债代码：123251 转债简称：华医转债 证券代码：301235 证券简称：华康洁净 公告编号：2025-108 武汉华康世纪洁净科技股份有限公司 关于持股5%以上股东减持股份的预披露公告 公司持股5%以上股东阳光人寿保险股份有限公司保证向本公司提供的信息内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 公司于近日收到持股5%以上股东阳光人寿出具的《关于股份减持计划的告知函》， 现将有关情况公告如下： 一、股东基本概况 阳光人寿持有公司股份5,605,246股，占本公司总股本（截至2025年9月4日总股 本为107,767,224股）比例为5.2013%，占剔除公司回购专用账户股份后总股本的 5.3709%（公司回购专用账户股份数为3,403,400股），股票来源为首次公开发行前已 发行的股份，均为无限售流通股。 注：本公告中持股比例、减持比例以公司截至2025年9月4日总股本数 107,767,224股为计算依据。 二、本次股东减持计划的主要内容 1、减持目的：经营发展需要； 2、股份来源：公司首次公开发行股票前已发行的股份； ...

Group 1 - The core point of the announcement is that Sunshine Life, a shareholder holding 5.2013% of Huakang Clean, plans to reduce its stake by up to 3.0000% of the total share capital within a specified timeframe [1] - The reduction will occur through centralized bidding and block trading methods, with a maximum of 323.3 million shares to be sold [1] - The selling period is set from September 29, 2025, to December 28, 2025, and there are specific limits on the amount that can be sold in any consecutive ninety-day period [1]

Group 1 - The company Huakang Clean announced its participation in the bidding for the "Medical Service Construction Project" [2] - The bidding unit is Qujing City Qilin District Urban Construction Real Estate Development Co., Ltd. [2] - The relevant list of candidates for the bid was published on September 5, 2025, by the Yunnan Provincial Public Resources Trading Information Network [2]

Group 1 - Huaneng Power announced that its shareholder Hunan Energy Group plans to reduce its stake by up to 20.31 million shares, not exceeding 1% of the total share capital [1] - Ankai Bus reported a production of 1,012 buses in August, a year-on-year increase of 68.06%, with sales of 773 buses, up 46.95% year-on-year [1] - Lianhuan Pharmaceutical received a drug registration certificate for Famotidine injection, classified as a Class 3 chemical drug [1][2] Group 2 - Dongrui Co. reported sales of 94,800 pigs in August, generating revenue of 160 million yuan, a month-on-month decrease of 5.48% [3] - Tiancheng Control's subsidiary received a notification for a passenger car seat assembly project, expected to start production in April 2026 [5] - ST Huluwa obtained a drug registration certificate for Cefodizime capsules, a third-generation broad-spectrum cephalosporin [6] Group 3 - Jiulong Biotech announced the resignation of its Vice Chairman and General Manager Liang Hongjun due to work adjustments [8] - Guanhua High-tech's shareholder plans to reduce its stake by up to 17.50 million shares, not exceeding 1% of the total share capital [9] - Hebei Steel received approval to issue bonds totaling up to 10 billion yuan [10] Group 4 - Yunnan Energy Investment's subsidiaries received a total of 309 million yuan in renewable energy price subsidies [12] - Zhenghong Technology reported sales of 16,800 pigs in August, with a revenue of 22.87 million yuan, showing a year-on-year increase in sales volume of 63.31% [14] - Jilin Aodong's subsidiary received a drug registration certificate for a solution used in asthma treatment [16] Group 5 - Aonong Biological reported a 26.84% year-on-year increase in pig sales volume in August, reaching 150,100 pigs [18] - Xingdesheng announced a share repurchase plan with a budget of 15 to 30 million yuan [20] - Yueyang Lin Paper's Chairman Ye Meng resigned due to work adjustments [22] Group 6 - Kangchen Pharmaceutical's controlling shareholder plans to reduce its stake by up to 4.78 million shares, not exceeding 3% of the total share capital [23] - Changchun Yidong's General Manager Liu Xiaodong resigned due to work adjustments [25] - Zhongzai Resources' subsidiary received a government subsidy of 12.75 million yuan [26] Group 7 - Tianyu Biological reported a 41.89% month-on-month increase in sales revenue from pig sales in August [27] - Changfei Optical's shareholder Draka Comteq B.V. reduced its stake from 10% to 5% [27] - Zhongchuan Technology's Chairman Wu Xingwang resigned due to work adjustments [28] Group 8 - Huakang Clean announced a successful bid for a medical service construction project valued at 131 million yuan [29] - Yuegui Co. plans to establish a wholly-owned subsidiary with a registered capital of 100 million yuan [31] - Baisheng Intelligent's Vice General Manager and Board Secretary Huang Lijun resigned for personal reasons [32] Group 9 - Jiangsu Shuntian will change its stock name to "Suhao Fashion" starting September 10, 2025 [34] - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.3759 million shares, not exceeding 1% of the total share capital [35] - Heng Rui Pharmaceutical received approval for clinical trials of HRS-4729 injection [37] Group 10 - Changfei Optical's shareholder plans to reduce its stake by up to 110,000 shares, not exceeding 0.15% of the total share capital [39] - Yutong Bus reported sales of 4,260 vehicles in August, a year-on-year increase of 16.78% [40] - JinkoSolar received 646 million yuan in renewable energy subsidies in August, a 248% increase year-on-year [41] Group 11 - Beijing Lier signed a strategic cooperation agreement with SenseTime and Xiwang Technology for AI collaboration [43] - Gongdong Medical's controlling shareholder plans to reduce its stake by up to 3% [44] - Zhonghuan Hailu terminated its control change plan and resumed trading [46] Group 12 - Longzi Co. reported a tax payment of 22.27 million yuan due to a tax audit [48] - Guoguang Chain's controlling shareholder plans to reduce its stake by up to 2.99% [49] - Guoxin Technology successfully tested a new high-performance chip for automotive electronics [50] Group 13 - GF Securities reported a cumulative increase in borrowings exceeding 20% of its net assets [51] - China Construction Bank's subsidiary plans to increase capital by 3 billion yuan [52] - Jifeng Technology plans to establish a wholly-owned subsidiary with a capital of 50 million yuan [53] Group 14 - Jiantou Energy received approval for a stock issuance plan to specific investors [54] - Shanghai Laishi's executives plan to collectively increase their holdings by at least 6 million yuan [55] - Wencan Co. reported a fire incident at its subsidiary, with no casualties reported [56]

Group 1 - The company Huakang Clean (301235.SZ) recently participated in a bidding for a "Medical Service Construction Project" [1] - The bidding was conducted by Qujing City Qilin District Urban Construction Real Estate Development Co., Ltd. [1] - The announced winning bid amount is approximately 131 million yuan [1]

Group 1 - The company, Huakang Clean (301235.SZ), recently participated in a bidding for a "Medical Service Construction Project" organized by Qujing City Qilin District Urban Construction Real Estate Development Co., Ltd. [1] - On September 5, 2025, the Yunnan Provincial Public Resource Trading Information Network announced the list of candidates for the bid, with the company being the first candidate. The winning bid amount is 131 million yuan, with a delivery period of 150 calendar days. [1] - The implementation of this project is expected to have a positive impact on the company's future operating performance, and the execution of the contract will not affect the company's operational independence. [1]

Group 1 - The company, Huakang Clean (301235.SZ), recently participated in a bidding for a "Medical Service Construction Project" organized by Qujing City Qilin District Urban Construction Real Estate Development Co., Ltd [1] - On September 5, 2025, the Yunnan Provincial Public Resources Trading Information Network announced the list of candidates, with the company being the first candidate with a winning bid of 131 million yuan [1] - The project is expected to have a positive impact on the company's future operating performance, and the execution of the contract will not affect the company's operational independence [1]

证券代码：301235 证券简称：华康洁净 公告编号：2025-107 转债代码：123251 转债简称：华医转债 武汉华康世纪洁净科技股份有限公司 关于项目预中标的提示性公告 4、第一名中标候选人：武汉华康世纪洁净科技股份有限公司 5、中标价：13,096.60109 万元 6、工期（交货期）：150 日历天 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示：本项目仍处于中标候选人公示阶段，其获取中标通知书、签约等 后续工作尚具有一定不确定性，敬请广大投资者注意投资风险。武汉华康世纪洁 净科技股份有限公司（以下简称"公司"）将根据相关事项后续进展情况履行相 应的信息披露义务。 公司于近日参与了"医疗服务建设工程"项目的投标，招标单位为曲靖市麒 麟区城建房地产开发有限公司。2025 年 9 月 5 日，云南省公共资源交易信息网 （https://ggzy.yn.gov.cn/）发布了相关中标候选人公示。现将具体预中标情 况提示如下： 一、预中标项目概况 1、招标单位名称：曲靖市麒麟区城建房地产开发有限公司 2、招标代理机构名称：云南兆宇工程管理咨询有限 ...